Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.

Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis

Abstract

Background Insulin-like growth factor (IGF)-I and its main binding protein, IGFBP-3, modulate cell growth and survival, and are thought to be important in tumour development. Circulating concentrations of IGF-I might be associated with an increased risk of cancer, whereas IGFBP-3 concentrations could be associated with a decreased cancer risk.Methods We did a systematic review and meta-regression analysis of case-control studies, including studies nested in cohorts, of the association between concentrations of IGF-I and IGFBP-3 and prostate, colorectal, premenopausal and postmenopausal breast, and lung cancer. Study-specific dose-response slopes were obtained by relating the natural log of odds ratios for different exposure levels to blood concentrations normalised to a percentile scale.Findings We identified 21 eligible studies (26 datasets), which included 3609 cases and 7137 controls. High concentrations of IGF-I were associated with an increased risk of prostate cancer (odds ratio comparing 75th with 25th percentile 1.49, 95% CI 1.14-1.95) and premenopausal breast cancer (1.65, 1.26-2.08) and high concentrations of IGFBP-3 were associated with increased risk of premenopausal breast cancer (1.51, 1.01-2.27). Associations were larger in assessments of plasma samples than in serum samples, and in standard case-control studies compared with nested studies.Interpretation Circulating concentrations of IGF-I and IGFBP-3 are associated with an increased risk of common cancers, but associations are modest and vary between sites. Although laboratory methods need to be standardised, these epidemiological observations could have major implications for assessment of risk and prevention of cancer.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(04)16044-3

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 64 references

Research works printed but not linked: 1

  1. Harvie, 2002, The effects of weight loss and exercise on biomarkers of breast cancer risk—rationale and study design, Recent Res Devel Nutrition, 5, 91

Cited by

See all 1,697

Metadata

Authors
Renehan, A. G., Zwahlen, M., Minder, C., O'Dwyer, S. T., Shalet, S. M., & Egger, M.
Affiliations
  • The Christie Hospital (GB)
  • University of Bern (CH)
Corresponding author
Renehan, Andrew G
Venue
The Lancet
Publisher
Elsevier BV
Published
2004-04
Volume
363
Issue
9418
Pages
1346-1353
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2111843196
Cited by
1,697
References
64
Citations by year
2026: 20 · 2025: 31 · 2024: 38 · 2023: 44 · 2022: 57 · 2021: 64 · 2020: 65 · 2019: 56 · 2018: 57 · 2017: 70 · 2016: 76 · 2015: 87 · 2014: 84 · 2013: 83 · 2012: 90
FWCI
15.36
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
  • Research Explorer (The University of Manchester) (publishedVersion)
  • Explore Bristol Research (submittedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
  • Health Sciences › Medicine › Oncology › Cancer Risks and Factors
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Keywords
insulin-like growth factor I, IGF binding protein-3, cancer risk, prostate cancer, colorectal cancer, breast cancer, lung cancer, dose-response relationship, circulating biomarkers, cancer prevention
MeSH terms
Breast Neoplasms, Female, Humans, Insulin-Like Growth Factor I, Lung Neoplasms, Male, Menopause, Neoplasms, Prostatic Neoplasms, Risk Factors, Colorectal Neoplasms, Premenopause, Insulin-Like Growth Factor Binding Protein 3

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. https://app.cochat.ai/papers/10.1016/s0140-6736(04)16044-3
The paper
Renehan, A. G., Zwahlen, M., Minder, C., O'Dwyer, S. T., Shalet, S. M., & Egger, M. (2004). Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. The Lancet. https://doi.org/10.1016/s0140-6736(04)16044-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.